Yang Kang

8PUBLICATIONS
7CO-AUTHORS
Molecular targetsChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 04, 2026
ROS Cascade-Amplified Polymeric Nanosystem Exhibiting Multi-Pathway Induction of Immunogenic Cell Death and Chemotherapeutic Efficacy in Tumor.

|Mar 04, 2026
Redox Dual-Responsive Drug Delivery System with Cascade of Reactive Oxygen Species Self-Generation for Enhanced Cancer Chemotherapy.

Ling Zeng, Ni Ding, Zhiyang Chen

|May 23, 2024
Paclitaxel Overload Supramolecular Oxidative Stress Nanoamplifier with a CDK12 Inhibitor for Enhanced Cancer Therapy.

Hao Zhang, Chengyuan Xing, Binyuan Yan

|Oct 19, 2023
Multimodal Nanoplatform with ROS Amplification to Overcome Multidrug Resistance in Prostate Cancer via Targeting P-Glycoprotein and Ferroptosis.

Yupeng Guan, Hanqi Lei, Chengyuan Xing

|Jul 18, 2023
A Cyclodextrin-Based pH-Responsive MicroRNA Delivery Platform Targeting Polarization of M1 to M2 Macrophages for Sepsis Therapy.

Ni Ding, Gangjian Luo, Huiting Li

|Apr 21, 2023
Glutathione and Esterase Dual-Responsive Smart Nano-drug Delivery System Capable of Breaking the Redox Balance for Enhanced Tumor Therapy.

Ping Shen, Xinyi Zhang, Ni Ding

Pageof 2

Frequent Collaborators

2 joint publications

Jun Pang

1 joint publications

Yanhuai Ding

1 joint publications

Zhipeng Gu

1 joint publications

Yining Wang